CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
Dan brings to CoreRx 25 years of experience as a global CDMO business leader and drug delivery innovator. Early in his career, Dan contributed to process and formulation development, particle engineering. and materials science innovations, resulting in more than 15 patents. Dan’s experience in the pharma services industry, manufacturing science and technology, product development, alliance management, and in corporate development will be a valued addition to the CoreRx team. Previously, Dan held leadership roles in Commercial Development at Lonza, Strategic Alliance Management at Capsugel, and as the Vice President of Engineering for Bend Research, Inc.
In his role as Chief Strategy Officer, Dan will oversee CoreRx’s strategy and corporate development functions. Dan will work closely with CoreRx’s Executive Leadership Team and Board of Directors in evaluating, developing, and executing CoreRx’s strategic growth initiatives.
“I’m thrilled to join CoreRx at this stage in its journey,” said Dan. “Looking to further build on a strong foundation of great people, technology, and customer service, we will create value for our clients and enable new medicines to reach the market.”
“This is an exciting time for CoreRx, with significant growth occurring across our business,” said Ajay Damani. “Dan brings a unique combination of technical background and experience in executive level decision-making and leadership that will strengthen our team.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!